Tumor testing to guide treatment for advanced cancers
Part of Cancer clinical trials.
This trial uses a patient's own tumor tissue to test which drugs might work best for cancers that have returned or not responded to previous treatments. It focuses on advanced gastric cancer and other solid tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have a confirmed advanced solid tumor, such as stomach or gastroesophageal junction cancer, that has not responded to treatment or has spread.
- You have at least one tumor that can be measured on scans and is large enough (more than 2 cm) to safely take a sample for testing.
- You have not had any systemic treatment yet, or your cancer progressed more than 6 months after finishing chemotherapy before surgery.
- You must be in generally good health (able to care for yourself) and have adequate organ function (bone marrow, liver, kidneys, heart).
- You are willing to provide tumor tissue for testing and to follow the study plan, including follow-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial tests a personalized cell therapy that uses your own immune cells, modified to target a specific genetic mutation found in some tumors. It aims to see if this treatment can shrink tumors or slow their growth in people with advanced cancer.
This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.
This trial tests whether FDA-approved targeted drugs can help people with advanced cancer whose tumors have specific gene changes. It aims to match your tumor's unique genetic profile to a drug that may work better for you.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.